Global Medical REIT Inc.
GMRE · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $41 | $38 | $35 | $35 |
| % Growth | 7.1% | 9.5% | -1% | – |
| Cost of Goods Sold | $23 | $8 | $8 | $7 |
| Gross Profit | $17 | $30 | $27 | $28 |
| % Margin | 42.7% | 78.3% | 78.1% | 79.4% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $5 | $6 | $4 | $8 |
| SG&A Expenses | $5 | $6 | $4 | $8 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $15 | $14 | $14 |
| Operating Expenses | $5 | $21 | $17 | $21 |
| Operating Income | $12 | $8 | $10 | $6 |
| % Margin | 30.7% | 22% | 27.6% | 18.3% |
| Other Income/Exp. Net | -$18 | -$8 | -$6 | -$3 |
| Pre-Tax Income | -$5 | $1 | $4 | $3 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$5 | $1 | $4 | $3 |
| % Margin | -11.2% | 1.7% | 10.3% | 8.1% |
| EPS | -0.37 | -0.3 | 0.788 | 0.515 |
| % Growth | -23.3% | -138.1% | 52.9% | – |
| EPS Diluted | -0.37 | -0.3 | 0.788 | 0.515 |
| Weighted Avg Shares Out | 13 | 3 | 3 | 3 |
| Weighted Avg Shares Out Dil | 13 | 3 | 3 | 3 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $8 | $7 | $8 |
| Depreciation & Amortization | $15 | $15 | $14 | $14 |
| EBITDA | $10 | $24 | $25 | $24 |
| % Margin | 24.5% | 63.1% | 72.1% | 69.8% |